Complete biochemical response following metastasis-directed radiotherapy for oligometastatic prostate cancer: A case report

Localized treatment has recently become an option for treating oligometastatic prostate cancer. Metastasis-directed therapy (MDT) is a new approach for localized treatment, and many clinical trials are ongoing. In the present case, biochemical recurrence occurred 8 months after a radical prostatecto...

Descripción completa

Detalles Bibliográficos
Autores principales: Okuda, Satoshi, Tabata, Ken-ichi, Shimura, Soichiro, Harano, Takahiro, Shiba, Izuru, Iwamura, Masatsugu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573857/
https://www.ncbi.nlm.nih.gov/pubmed/33102017
http://dx.doi.org/10.1016/j.eucr.2020.101315
Descripción
Sumario:Localized treatment has recently become an option for treating oligometastatic prostate cancer. Metastasis-directed therapy (MDT) is a new approach for localized treatment, and many clinical trials are ongoing. In the present case, biochemical recurrence occurred 8 months after a radical prostatectomy for localized prostate cancer, and oligometastases were diagnosed via whole-body magnetic resonance imaging. Metastasis-directed radiotherapy (MDRT) was performed on all oligometastatic sites. After MDRT without androgen deprivation therapy, the prostate-specific antigen (PSA) decreased to an undetectable level and did not increase for 24 months.

Ejemplares similares